Literature DB >> 7646820

What is the true clinical significance of plasma protein binding displacement interactions?

L N Sansom1, A M Evans.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7646820     DOI： 10.2165/00002018-199512040-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  21 in total

1.  Drug Interactions: A Source Book of Adverse Interactions, Their Mechanisms, Clinical Importance and Management.

Authors: 
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391

Review 2.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

3.  Warfarin-chloral hydrate interaction. Pharmacological activity and clinical significance.

Authors:  J A Udall
Journal:  Ann Intern Med       Date:  1974-09       Impact factor: 25.391

4.  Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.

Authors:  E M Sellers; J Koch-Weser
Journal:  N Engl J Med       Date:  1970-10-15       Impact factor: 91.245

Review 5.  Plasma protein binding displacement interactions--why are they still regarded as clinically important?

Authors:  P E Rolan
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

6.  Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.

Authors:  A Monks; A Richens
Journal:  Clin Pharmacol Ther       Date:  1980-01       Impact factor: 6.875

7.  Kinetics of drug displacement interactions.

Authors:  L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

8.  Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.

Authors:  T D Bjornsson; P J Meffin; S Swezey; T F Blaschke
Journal:  J Pharmacol Exp Ther       Date:  1979-09       Impact factor: 4.030

9.  Interaction between diflunisal and warfarin.

Authors:  M J Serlin; S Mossman; R G Sibeon; K F Tempero; A M Breckenridge
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

10.  Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors:  A Monks; S Boobis; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335
View more
  11 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery.

Authors:  Dennis A Smith; Li Di; Edward H Kerns
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 3.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

4.  Clinically significant psychotropic drug-drug interactions in the primary care setting.

Authors:  Brett A English; Marcus Dortch; Larry Ereshefsky; Stanford Jhee
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

Review 5.  Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.

Authors:  M Barry; S Gibbons; D Back; F Mulcahy
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

6.  Stress can affect drug pharmacokinetics via serum/tissues protein binding and blood flow rate alterations.

Authors:  Kotsiou Antonia; Alevizou Anastasia; Christine Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-12-16       Impact factor: 2.441

7.  The clinical relevance of plasma protein binding changes.

Authors:  Jason A Roberts; Federico Pea; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

8.  The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.

Authors:  P J Tiseo; K Foley; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 9.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  Clinical pharmacology of deferasirox.

Authors:  Chiaki Tanaka
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 5.577
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.